Skip to main content

Publications

featured publications

  • Myeloperoxidase and anti-MPO IgG synergistically enhance TLR9-mediated immune activation in ANCA-associated vasculitis.

    Cell reports

    Authors: Calvin Krollmann, Maria-Lourdes Saenz, Ruth-Miriam Koerber, Kevin Cieslak, Angela Rösen-Wolff, Peter Brossart, Valentin S Schäfer, Natalio Garbi, Abraham Rutgers, Peter Heeringa, Lino L Teichmann

  • Explainable artificial intelligence reveals key surgical parameters in robot-assisted and open radical prostatectomy.

    Scientific reports

    Authors: Christian R Klein, Pia Heuser, Elena Trunz, Glen Kristiansen, Peter Brossart, Manuel Ritter, Philipp Krausewitz

  • CD103+ tissue-resident T-cells in head and neck squamous cell carcinomas of patients treated anti-PD-1 therapy.

    Cancer treatment and research communications

    Authors: Christine Sanders, Dahlia Kittel, Annkristin Heine, Sebastian Strieth, Tessa Hattenhauer, Rebekka Mispelbaum, Dimo Dietrich, Glen Kristiansen, Peter Brossart, Marieta Ioana Toma

  • Case Report: Life-saving emergency chemotherapy in a critically ill patient with suspected metastatic testicular cancer prior to histological confirmation.

    Frontiers in oncology

    Authors: Victoria John von Freyend, Moritz Kleemiss, Alexander Cox, Katjana Schwab, Peter Brossart, Michael Serries

  • Inhibition of Fibroblast Growth Factor Receptor 3 Signaling by Ponatinib Reduces Growth and Cytokine Production of Multiple Myeloma Cells.

    International journal of molecular sciences

    Authors: Sascha Kampmann, Sebastian Schlaweck, Benjamin V Becker, Chrystel Flores, Annkristin Heine, Peter Brossart, Stefanie A E Held

  • Clinical efficacy and immunological aspects of neoadjuvant and perioperative therapy in resectable head and neck carcinoma.

    Cancer treatment reviews

    Authors: Tessa Hattenhauer, Rebekka Mispelbaum, Franz-Georg Bauernfeind, Georg Feldmann, Dirk Baumjohann, Johannes Brägelmann, Annkristin Heine, Peter Brossart

  • Longer time to response in hemato-oncological patients with immune thrombocytopenia (ITP): a pilot study.

    Expert review of hematology

    Authors: Tessa Hattenhauer, Rebekka Mispelbaum, Peter Brossart, Carmen Kuehn, Annkristin Heine

  • Hypomethylating Agents and Venetoclax Based Triplets Targeting FLT3, IDH and KMT2A in Acute Myeloid Leukemia: Current Studies and Challenges of a Tailored Approach.

    Cancers

    Authors: Elisa Santambrogio, Alessia Castellino, Ernesta Audisio, Martin Schumacher, Georg Feldmann, Raheel Iftikhar, Peter Brossart, Semra Aydin

  • NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms.

    Nature communications

    Authors: Ruth-Miriam Koerber, Calvin Krollmann, Kevin Cieslak, Elisabeth Tregel, Maria L Saenz, Tim H Brümmendorf, Steffen Koschmieder, Martin Griesshammer, Ines Gütgemann, Conny K Baldauf, Thomas Fischer, Peter Brossart, Carl Christian Kolbe, Eicke Latz, Dominik Wolf, Lino L Teichmann

  • Prognostic Impact of the Hevylite Assay in Patients With IgG or IgA Multiple Myeloma Treated Within the GMMG-MM5 Trial.

    European journal of haematology

    Authors: Tim Richardson, Elias Mai, Ekaterina Menis, Axel Benner, Diana Tichy, Kaya Miah, Mathias Hänel, Britta Besemer, Amelie Boquoi, Igor Wolfgang Blau, Christian S Michel, Hans Walter Lindemann, Snjezana Janjetovic, Peter Brossart, Helga Bernhard, Peter Reimer, Hans Salwender, Dirk Hose, Anja Seckinger, Marc Raab, Hartmut Goldschmidt, Christof Scheid